Modular Medical financials
$1.95−2.74%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Mar 31 | FY25 Mar 31 | FY24 Mar 31 | FY23 Mar 31 | FY22 Mar 31 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — |
| Operating income | -$27.6M | -$19.0M | -$17.5M | -$13.9M | -$14.9M |
| Net income | -$28.2M | -$18.8M | -$17.5M | -$13.9M | -$18.6M |
| Net margin | — | — | — | — | — |
| Diluted EPS | $-12.36 | $-15.26 | $-23.40 | $-34.50 | $-82.20 |
| EBITDA | -$25.9M | -$18.0M | -$17.1M | -$13.7M | -$14.8M |
| Operating cash flow | -$23.8M | -$15.7M | -$14.0M | -$11.0M | -$10.3M |
| Free cash flow | -$27.7M | -$18.2M | -$15.7M | -$12.6M | -$10.3M |
| Diluted shares | 2.3M | 1.2M | 0.7M | 0.4M | 0.2M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $6.9M | $13.1M | $9.2M | $3.8M | $9.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $14.8M | $18.7M | $13.8M | $7.2M | $9.8M |
| Total liabilities | $1.9M | $1.7M | $2.3M | $2.2M | $1.0M |
| Shareholders' equity | $13.0M | $17.1M | $11.5M | $5.1M | $8.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology